CN Bio and Altis Biosystems, Inc. (“Altis”), leading developers of in vitro human organ models that optimize the accuracy and efficiency of drug development, today announced a strategic partnership.

SOMERVILLE, Mass., December 04, 2024--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) ("bluebird bio") today announced it has reached an agreement with the Center for Medicare and Medicaid ...

The National Institute of Standards and Technology’s Artificial Intelligence Safety Institute is seeking information on the development of chemical and biology-focused artificial intelligence models.

bit.bio, a synthetic biology company working on developing and providing every human cell type at scale, with the aim of transforming the research and medicine landscape, today launch their ...

Immunology startup Parallel Bio has released a model of the human immune system that is said to capture the way immunotherapies affect the body more accurately than animals. The so-called “Clinical ...

ChatGPT-parent OpenAI has acknowledged that its latest model, known as “o1,” could potentially be misused for creating biological weapons. What Happened: Last week, OpenAI unveiled its new model, ...

A new generative AI model trained on UK Biobank data can simultaneously forecast the risks and timing of developing over 1,000 different diseases a decade into the future. The developers applied ...

Building models is a key element of today’s science behind bioprocessing. The value of such models, however, depends on the information being produced. To improve models of bioprocessing, Mariana ...

Intelligent Bio Solutions ( ($INBS) ) just unveiled an update. Intelligent Bio Solutions Inc. provided a presentation to investors on December 2, ...